Invention Grant
- Patent Title: Modified vaccinia virus ankara for the vaccination of neonates
- Patent Title (中): 改良的痘苗病毒安卡拉用于接种新生儿
-
Application No.: US12118841Application Date: 2008-05-12
-
Publication No.: US07897156B2Publication Date: 2011-03-01
- Inventor: Mathias Ackermann , Mark Suter , Hans Peter Hefti , Marco Franchini , Sabine Vollstedt , Paul Chaplin
- Applicant: Mathias Ackermann , Mark Suter , Hans Peter Hefti , Ruth Hefti, legal representative , Marco Franchini , Sabine Vollstedt , Paul Chaplin
- Applicant Address: DK Kvistgaard
- Assignee: Bavarian Nordic A/S
- Current Assignee: Bavarian Nordic A/S
- Current Assignee Address: DK Kvistgaard
- Agency: Law Office of Salvatore Arrigo
- Priority: DK200200590 20020419
- Main IPC: A61K31/285
- IPC: A61K31/285
Abstract:
The invention concerns the use of a virus to increase the number of dendritic cells or their precursor cells in an immunocompromised animal, including a human. The virus is preferably a Modified Vaccinia Virus Ankara which is capable of infecting the cells of a neonatal or prenatal animal, including a human, but not capable of being replicated to infectious progeny virus in the neonatal or prenatal animal, including a human.
Public/Granted literature
- US20090104224A1 MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCINATION OF NEONATES Public/Granted day:2009-04-23
Information query
